These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23908534)

  • 1. GRAPPA Fellows Symposium adjacent to the European Academy of Dermatology and Venerology meeting, Verona, 2012: a meeting report.
    Boehncke WH; Kirby B
    J Rheumatol; 2013 Aug; 40(8):1410-2. PubMed ID: 23908534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRAPPA Fellows Symposium Adjacent to the European Academy of Dermatology and Venereology (EADV) Congress, Istanbul, 2013: a meeting report.
    Boehncke WH; Kirby B; Thaci D
    J Rheumatol; 2014 Jun; 41(6):1197-9. PubMed ID: 24882851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Boehncke WH; Gladman DD
    J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Boehncke WH; Gladman DD
    J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.
    Cauli A; Lubrano E; Scarpa R; Olivieri I
    J Rheumatol; 2012 Nov; 39(11):2201-3. PubMed ID: 23118288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M; Joseph GJ; Princic N; Harrison DJ
    J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2181-3. PubMed ID: 23118282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
    J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.
    van den Reek JM; Zweegers J; Kievit W; Otero ME; van Lümig PP; Driessen RJ; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; van de Kerkhof PC; Seyger MM; de Jong EM
    Br J Dermatol; 2014 Nov; 171(5):1189-96. PubMed ID: 24807471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prologue: 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Gladman DD
    J Rheumatol; 2011 Mar; 38(3):522-5. PubMed ID: 21362779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor inhibitors in psoriasis: an update.
    Kerdel FA; Strober BE
    Semin Cutan Med Surg; 2014 Mar; 33(2 Suppl 2):S31-6. PubMed ID: 24979543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ustekinumab for the treatment of psoriasis: review of three multicenter clinical trials.
    Farhi D
    Drugs Today (Barc); 2010 Apr; 46(4):259-64. PubMed ID: 20502723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
    Chu DH; Van Voorhees AS; Rosenbach M
    Arch Dermatol; 2011 Oct; 147(10):1228-30. PubMed ID: 22006150
    [No Abstract]   [Full Text] [Related]  

  • 16. Prologue: 2010 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Mease PJ; Gladman DD
    J Rheumatol; 2012 Feb; 39(2):391-3. PubMed ID: 22298263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic patients treated with etanercept.
    Giunta A; Babino G; Manetta S; Mazzotta A; Chimenti S; Esposito M
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S27-30. PubMed ID: 25381970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Helliwell PS; Gladman DD; Gottlieb AB
    J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
    Helliwell PS; Gladman DD; Gottlieb AB
    J Rheumatol; 2017 May; 44(5):658-660. PubMed ID: 28461520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrodermic psoriasis: current and future role of biologicals.
    Stinco G; Errichetti E
    BioDrugs; 2015 Apr; 29(2):91-101. PubMed ID: 25752640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.